PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
152 hedge funds and large institutions have $478M invested in Progenics Pharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 153 → 152 (-1)
Holders
152
Holding in Top 10
–
Calls
$12M
Puts
$10.6M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$2.54M | |
| 3 | +$2.31M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.25M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$2.24M |
Top Sellers
| 1 | -$6.3M | |
| 2 | -$2.86M | |
| 3 | -$1.55M | |
| 4 |
PA
Pinnacle Associates
New York
|
-$831K |
| 5 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
-$520K |